Literature DB >> 19639291

Adenosine receptors and the kidney.

Volker Vallon1, Hartmut Osswald.   

Abstract

The autacoid, adenosine, is present in the normoxic kidney and generated in the cytosol as well as at extracellular sites. The rate of adenosine formation is enhanced when the rate of ATP hydrolysis prevails over the rate of ATP synthesis during increased tubular transport work or during oxygen deficiency. Extracellular adenosine acts on adenosine receptor subtypes (A(1), A(2A), A(2B), and A(3)) in the cell membranes to affect vascular and tubular functions. Adenosine lowers glomerular filtration rate by constricting afferent arterioles, especially in superficial nephrons, and thus lowers the salt load and transport work of the kidney consistent with the concept of metabolic control of organ function. In contrast, it leads to vasodilation in the deep cortex and the semihypoxic medulla, and exerts differential effects on NaCl transport along the tubular and collecting duct system. These vascular and tubular effects point to a prominent role of adenosine and its receptors in the intrarenal metabolic regulation of kidney function, and, together with its role in inflammatory processes, form the basis for potential therapeutic approaches in radiocontrast media-induced acute renal failure, ischemia reperfusion injury, and in patients with cardiorenal failure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19639291      PMCID: PMC6027627          DOI: 10.1007/978-3-540-89615-9_15

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  172 in total

1.  Macula densa cell signaling involves ATP release through a maxi anion channel.

Authors:  Phillip Darwin Bell; Jean-Yves Lapointe; Ravshan Sabirov; Seiji Hayashi; Janos Peti-Peterdi; Ken-Ichi Manabe; Gergely Kovacs; Yasunobu Okada
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

2.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

3.  Effects of graded oxygen tension on adenosine release by renal medullary and thick ascending limb suspensions.

Authors:  R E Beach; B A Watts; D W Good; C R Benedict; T D DuBose
Journal:  Kidney Int       Date:  1991-05       Impact factor: 10.612

4.  Combined effects of carbonic anhydrase inhibitor and adenosine A1 receptor antagonist on hemodynamic and tubular function in the kidney.

Authors:  Cynthia M Miracle; Timo Rieg; Roland C Blantz; Volker Vallon; Scott C Thomson
Journal:  Kidney Blood Press Res       Date:  2007-09-20       Impact factor: 2.687

5.  Interaction of adenosine with vasopressin in the inner medullary collecting duct.

Authors:  Y Yagil
Journal:  Am J Physiol       Date:  1990-10

6.  Protective effects of KW-3902, a novel adenosine A1-receptor antagonist, against gentamicin-induced acute renal failure in rats.

Authors:  K Yao; H Kusaka; K Sato; A Karasawa
Journal:  Jpn J Pharmacol       Date:  1994-06

7.  A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion.

Authors:  H Thomas Lee; Hua Xu; Samih H Nasr; Jurgen Schnermann; Charles W Emala
Journal:  Am J Physiol Renal Physiol       Date:  2003-11-04

8.  Bimodal acute effects of A1 adenosine receptor activation on Na+/H+ exchanger 3 in opossum kidney cells.

Authors:  Francesca Di Sole; Robert Cerull; Soeren Petzke; Valeria Casavola; Gerhard Burckhardt; Corinna Helmle-Kolb
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

9.  Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study.

Authors:  Barry Greenberg; Ignatius Thomas; Dorothy Banish; Steven Goldman; Edward Havranek; Barry M Massie; Ying Zhu; Barry Ticho; William T Abraham
Journal:  J Am Coll Cardiol       Date:  2007-07-30       Impact factor: 24.094

10.  Dipyridamole decreases glomerular filtration in the sodium-depleted dog. Evidence for mediation by intrarenal adenosine.

Authors:  L J Arend; C I Thompson; W S Spielman
Journal:  Circ Res       Date:  1985-02       Impact factor: 17.367

View more
  35 in total

Review 1.  Anticancer effect of adenosine on gastric cancer via diverse signaling pathways.

Authors:  Ayako Tsuchiya; Tomoyuki Nishizaki
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 3.  Regulation of luminal acidification by the V-ATPase.

Authors:  Sylvie Breton; Dennis Brown
Journal:  Physiology (Bethesda)       Date:  2013-09

Review 4.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

5.  Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia.

Authors:  Petra Szoleczky; Katalin Módis; Nóra Nagy; Zoltán Dóri Tóth; Douglas DeWitt; Csaba Szabó; Domokos Gero
Journal:  Arch Biochem Biophys       Date:  2011-11-11       Impact factor: 4.013

6.  Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.

Authors:  Hicham Labazi; Stephen L Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2015-12-30       Impact factor: 4.030

Review 7.  Adenosine and protection from acute kidney injury.

Authors:  Steven C Yap; H Thomas Lee
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

8.  Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.

Authors:  Weiru Zhang; Yujin Zhang; Wei Wang; Yingbo Dai; Chen Ning; Renna Luo; Kaiqi Sun; Louise Glover; Almut Grenz; Hong Sun; Lijian Tao; Wenzheng Zhang; Sean P Colgan; Michael R Blackburn; Holger K Eltzschig; Rodney E Kellems; Yang Xia
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

9.  Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries.

Authors:  Bunyen Teng; Daniel Fil; Stephen L Tilley; Catherine Ledent; Thomas Krahn; S Jamal Mustafa
Journal:  J Cardiovasc Pharmacol       Date:  2013-01       Impact factor: 3.105

10.  Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.

Authors:  Daniela Patinha; Angelica Fasching; Dora Pinho; António Albino-Teixeira; Manuela Morato; Fredrik Palm
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.